Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Disruptive Bio Trading ApS
APS
Active
Advertising protection
CVR 41532580
Skyttevænget 9, 8370
Hadsten
Non-specialised wholesale trade
·
NACE 4690
Est. 2020 · 6 years old
4 employees
www.disruptivebiotrading.com
Monitor
Share
Denmark
/
Companies
/
Non-specialised wholesale trade
/
Disruptive Bio Trading ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
125M
93M
62M
31M
0M
2021: 57M
57M
2021
2022: 100M (+75% vs 2021)
100M
+75%
2022
2023: 32M (-68% vs 2022)
32M
-68%
2023
2024: 5M (-84% vs 2023)
5M
-84%
2024
2025: 8M (+60% vs 2024)
8M
+60%
2025
EBITDA
DKK millions
12M
9M
6M
3M
0M
2021: 1M
1M
2021
2022: 10M (+900% vs 2021)
10M
+900%
2022
2023: 1M (-90% vs 2022)
1M
-90%
2023
2024: 2M (+100% vs 2023)
2M
+100%
2024
2025: 5M (+150% vs 2024)
5M
+150%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
7.991
5.024
31.874
100.000
57.403
Staff expenses
-2.798
-2.758
-3.444
-4.441
-1.719
EBITDA
5.193
2.266
552
10.446
1.296
Depreciation & amort.
-43
-43
-16
-9
-1
EBIT
5.149
2.223
536
10.437
1.295
Net financials
-259
-294
-105
-196
-60
Profit before tax
4.890
1.929
431
10.241
1.235
Tax
1.076
430
107
2.267
274
Net profit
3.814
1.499
324
7.974
961
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
11.464
8.444
7.694
18.884
9.043
Equity
4.086
1.547
1.098
8.774
1.001
Long-term debt
0
0
0
0
0
Short-term debt
7.355
6.871
6.573
10.099
8.040
Total debt
7.355
6.871
6.573
10.099
8.040
Financial ratios
5-year trend
EBITDA margin
65,0 %
This company
15,8 %
Market median
This company
Market median
311% above market
2021
2025
Equity ratio
35,6 %
This company
38,2 %
Market median
This company
Market median
7% below market
2021
2025
Return on equity
93,3 %
This company
18,4 %
Market median
This company
Market median
407% above market
2021
2025
Net profit margin
47,7 %
This company
8,1 %
Market median
This company
Market median
489% above market
2021
2025
Asset turnover
0,70×
This company
1,12×
Market median
This company
Market median
38% below market
2021
2025
Debt / equity
1,81×
This company
0,62×
Market median
This company
Market median
192% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-07-14 – 2021-12-31
View
PDF
More on Disruptive Bio Trading ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
